INFASURF PRESERVATIVE FREE (calfactant) by Ony Biotech is surfactant activity [moa]. First approved in 1998.
Drug data last refreshed 17h ago · AI intelligence enriched 1mo ago
INFASURF PRESERVATIVE FREE is a pulmonary surfactant replacement therapy administered via intratracheal instillation as a suspension. It is indicated for respiratory distress syndrome (RDS) in premature infants, where it reduces surface tension in the lungs to improve gas exchange. The drug works through surfactant activity, mimicking the natural lung surfactant deficient in preterm neonates.
Product is approaching loss of exclusivity with moderate competitive pressure (30%), indicating a mature franchise with declining growth opportunities and potential team restructuring.
Surfactant Activity
Surfactant
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on INFASURF offers limited career growth potential given the LOE-approaching lifecycle and minimal linked job openings. This role is best suited for professionals seeking stable, specialized experience in neonatal respiratory therapy rather than high-growth career acceleration.
Worked on INFASURF PRESERVATIVE FREE at Ony Biotech? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.